companydata.dkNectar RHS Komplementar ApS: Financial statements 2024
CVR: 41934530
Nectar RHS Komplementar ApS (CVR 41934530) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,000 and a net result of DKK 58,075 compared with DKK 15,307 the year before. Equity amounted to DKK 138,567. The solvency ratio was 86.4%. The company had 1 employee in the financial year.
- Gross Profit
- -5,000 kr.
- Profit/Loss
- 58,075 kr.
- Equity
- 138,567 kr.
- Total Assets
- 160,316 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -5 t. | 58 t. | 139 t. | 1 |
| 2023 | - | -5 t. | 15 t. | 80 t. | 1 |
| 2022 | - | -13 t. | 10 t. | 65 t. | 0 |
| 2021 | - | -5 t. | 16 t. | 56 t. | 0 |
How creditworthy is Nectar RHS Komplementar ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Nectar RHS Komplementar ApS has published its annual report for 2023. Gross profit came to DKK -5,000, and the net result was DKK 15,307.
About Nectar RHS Komplementar ApS
Nectar RHS Komplementar ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Bjørk Krogshave. The company is owned by PharmaService I/S and Nectar Invest A/S. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 38,849 compared with DKK 58,075 the year before. Equity amounted to DKK 177,416.